Directed fusion of mesenchymal stem cells with cardiomyocytes via VSV-G facilitates stem cell programming

Nicholas A. Kouris, Jeremy A. Schaefer, Masato Hatta, Brian T. Freeman, Timothy J. Kamp, Yoshihiro Kawaoka, Brenda M. Ogle

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) spontaneously fuse with somatic cells in vivo, albeit rarely, and the fusion products are capable of tissue-specific function (mature trait) or proliferation (immature trait), depending on the microenvironment. That stem cells can be programmed, or somatic cells reprogrammed, in this fashion suggests that stem cell fusion holds promise as a therapeutic approach for the repair of damaged tissues, especially tissues not readily capable of functional regeneration, such as the myocardium. In an attempt to increase the frequency of stem cell fusion and, in so doing, increase the potential for cardiac tissue repair, we expressed the fusogen of the vesicular stomatitis virus (VSV-G) in human MSCs. We found VSV-G expressing MSCs (vMSCs) fused with cardiomyocytes (CMs) and these fusion products adopted a CM-like phenotype and morphology in vitro. In vivo, vMSCs delivered to damaged mouse myocardium via a collagen patch were able to home to the myocardium and fuse to cells within the infarct and peri-infarct region of the myocardium. This study provides a basis for the investigation of the biological impact of fusion of stem cells with CMs in vivo and illustrates how viral fusion proteins might better enable such studies.

Original languageEnglish (US)
Article number414038
JournalStem Cells International
DOIs
StatePublished - Jun 20 2012

Fingerprint

Mesenchymal Stromal Cells
Cardiac Myocytes
Myocardium
Stem Cells
Cell Fusion
Viral Fusion Proteins
Vesicular Stomatitis
Regeneration
Collagen
Viruses
Phenotype
Therapeutics

Cite this

Directed fusion of mesenchymal stem cells with cardiomyocytes via VSV-G facilitates stem cell programming. / Kouris, Nicholas A.; Schaefer, Jeremy A.; Hatta, Masato; Freeman, Brian T.; Kamp, Timothy J.; Kawaoka, Yoshihiro; Ogle, Brenda M.

In: Stem Cells International, 20.06.2012.

Research output: Contribution to journalArticle

Kouris, Nicholas A. ; Schaefer, Jeremy A. ; Hatta, Masato ; Freeman, Brian T. ; Kamp, Timothy J. ; Kawaoka, Yoshihiro ; Ogle, Brenda M. / Directed fusion of mesenchymal stem cells with cardiomyocytes via VSV-G facilitates stem cell programming. In: Stem Cells International. 2012.
@article{8b93acb322f54cf7b756dfc08ea9773b,
title = "Directed fusion of mesenchymal stem cells with cardiomyocytes via VSV-G facilitates stem cell programming",
abstract = "Mesenchymal stem cells (MSCs) spontaneously fuse with somatic cells in vivo, albeit rarely, and the fusion products are capable of tissue-specific function (mature trait) or proliferation (immature trait), depending on the microenvironment. That stem cells can be programmed, or somatic cells reprogrammed, in this fashion suggests that stem cell fusion holds promise as a therapeutic approach for the repair of damaged tissues, especially tissues not readily capable of functional regeneration, such as the myocardium. In an attempt to increase the frequency of stem cell fusion and, in so doing, increase the potential for cardiac tissue repair, we expressed the fusogen of the vesicular stomatitis virus (VSV-G) in human MSCs. We found VSV-G expressing MSCs (vMSCs) fused with cardiomyocytes (CMs) and these fusion products adopted a CM-like phenotype and morphology in vitro. In vivo, vMSCs delivered to damaged mouse myocardium via a collagen patch were able to home to the myocardium and fuse to cells within the infarct and peri-infarct region of the myocardium. This study provides a basis for the investigation of the biological impact of fusion of stem cells with CMs in vivo and illustrates how viral fusion proteins might better enable such studies.",
author = "Kouris, {Nicholas A.} and Schaefer, {Jeremy A.} and Masato Hatta and Freeman, {Brian T.} and Kamp, {Timothy J.} and Yoshihiro Kawaoka and Ogle, {Brenda M.}",
year = "2012",
month = "6",
day = "20",
doi = "10.1155/2012/414038",
language = "English (US)",
journal = "Stem Cells International",
issn = "1687-9678",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Directed fusion of mesenchymal stem cells with cardiomyocytes via VSV-G facilitates stem cell programming

AU - Kouris, Nicholas A.

AU - Schaefer, Jeremy A.

AU - Hatta, Masato

AU - Freeman, Brian T.

AU - Kamp, Timothy J.

AU - Kawaoka, Yoshihiro

AU - Ogle, Brenda M.

PY - 2012/6/20

Y1 - 2012/6/20

N2 - Mesenchymal stem cells (MSCs) spontaneously fuse with somatic cells in vivo, albeit rarely, and the fusion products are capable of tissue-specific function (mature trait) or proliferation (immature trait), depending on the microenvironment. That stem cells can be programmed, or somatic cells reprogrammed, in this fashion suggests that stem cell fusion holds promise as a therapeutic approach for the repair of damaged tissues, especially tissues not readily capable of functional regeneration, such as the myocardium. In an attempt to increase the frequency of stem cell fusion and, in so doing, increase the potential for cardiac tissue repair, we expressed the fusogen of the vesicular stomatitis virus (VSV-G) in human MSCs. We found VSV-G expressing MSCs (vMSCs) fused with cardiomyocytes (CMs) and these fusion products adopted a CM-like phenotype and morphology in vitro. In vivo, vMSCs delivered to damaged mouse myocardium via a collagen patch were able to home to the myocardium and fuse to cells within the infarct and peri-infarct region of the myocardium. This study provides a basis for the investigation of the biological impact of fusion of stem cells with CMs in vivo and illustrates how viral fusion proteins might better enable such studies.

AB - Mesenchymal stem cells (MSCs) spontaneously fuse with somatic cells in vivo, albeit rarely, and the fusion products are capable of tissue-specific function (mature trait) or proliferation (immature trait), depending on the microenvironment. That stem cells can be programmed, or somatic cells reprogrammed, in this fashion suggests that stem cell fusion holds promise as a therapeutic approach for the repair of damaged tissues, especially tissues not readily capable of functional regeneration, such as the myocardium. In an attempt to increase the frequency of stem cell fusion and, in so doing, increase the potential for cardiac tissue repair, we expressed the fusogen of the vesicular stomatitis virus (VSV-G) in human MSCs. We found VSV-G expressing MSCs (vMSCs) fused with cardiomyocytes (CMs) and these fusion products adopted a CM-like phenotype and morphology in vitro. In vivo, vMSCs delivered to damaged mouse myocardium via a collagen patch were able to home to the myocardium and fuse to cells within the infarct and peri-infarct region of the myocardium. This study provides a basis for the investigation of the biological impact of fusion of stem cells with CMs in vivo and illustrates how viral fusion proteins might better enable such studies.

UR - http://www.scopus.com/inward/record.url?scp=84862298207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862298207&partnerID=8YFLogxK

U2 - 10.1155/2012/414038

DO - 10.1155/2012/414038

M3 - Article

C2 - 22701126

AN - SCOPUS:84862298207

JO - Stem Cells International

JF - Stem Cells International

SN - 1687-9678

M1 - 414038

ER -